With President Trump’s signing of HR 7148, experts are now racing to get a grasp on the monumental shifts in pharmacy that will stem from this new legislation.
Jesse Dresser, Esq
Advertisement
Jesse Dresser, Esq, partner in the Life Sciences Department and head of the Pharmacy Practice Group at Frier Levitt Attorneys at Law
Articles by Jesse Dresser, Esq
As lawmakers continue to deliberate on HR 7148, pharmacy law expert, Jesse Dresser, Esq, joined Drug Topics to discuss its provisions related to PBMs.
If signed by President Trump in time to avoid a government shutdown, HR 7148 has potential to enforce significant change in the prescription drug supply chain.
Advertisement
Latest Updated Articles
What the Newest Landmark PBM Reform Means for the Pharmacy IndustryFebruary 5th 2026
Advertisement
Advertisement
Trending on Drug Topics
1
PBM Underpayment Persists as Cost-Plus Brings New Strain | NCPA 2026
2
Pharmacist Roles, Risks in Guiding AI-Enabled Medical Device Use
3
Q&A: Why Enforcement Is the Weak Link in State PBM Reform | NCPA 2026
4
Vaccine Fatigue May Stall Patient Uptake More Than Hesitancy
5